Form 4: West Pharmaceutical Services Director Douglas Michels Reports Acquisition of Restricted Stock Units

Director Douglas Michels reported the acquisition of 1,071 restricted stock units in West Pharmaceutical Services, Inc.

Summary

• On May 6, 2025, Douglas Michels, a director of West Pharmaceutical Services Inc., reported acquiring 1,071 shares of common stock.
• These shares were received as restricted stock units, priced at $0.
• Following the transaction, Michels directly owns 45,171.05 shares of West Pharmaceutical Services Inc.
• The restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock units by a director is generally seen as a positive sign, indicating alignment with the company's future performance. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted stock units indicates continued alignment of the director's interests with the company's long-term performance.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder confidence by demonstrating alignment of interests.

Next Steps

• The restricted stock units will vest at the next annual shareholder meeting.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Director, West Pharmaceutical Services, WST, Douglas Michels